Zymeworks Inc.
Key Metrics
Market Snapshot
About
Zymeworks is a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics for cancer and other diseases. The company specializes in bispecific antibodies that can simultaneously engage two different targets, potentially offering improved efficacy over traditional antibody therapies. Zymeworks uses proprietary technology platforms to create differentiated therapeutic candidates.